InnoCan Pharma Corporation (INNO)
Market Closed
15 Jun, 20:00
CNSX 
CA$
3. 30
-0.1
-2.9412%
CA$
- Market Cap
- P/E Ratio
- Div Yield
480 Volume
- Eps
CA$ 3.4
Previous Close Want to track INNO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoCan Pharma Corporation (INNO) Statistics
Valuation metrics
Market Cap -
Enterprise value 5.68M
Trailing P/E (ttm) -7.3
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 0.43
Price/Book (mrq) 2.1
Enterprise Value/Revenue 0.23
Enterprise Value/EBITDA -8.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 489
Average volume (90 days) 760
Price summary
52-Week low 3.01
52-Week high 21
Beta -
50-Day moving average 4.6
200-Day moving average 6.85
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:65
Last split Date 5 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.06%
Operating margin -0.1%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.6
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.48
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 5.24%
Book value per share (mrq) 1.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
